Lumasiran therapy provided durable reductions in urinary and plasma oxalate levels over five years in infants and young children with primary hyperoxaluria type 1, alongside improved nephrocalcinosis and...
New research offers insight on survival outcomes in patients with end-stage renal disease who undergo hemodialysis at home vs in-center. The findings were presented at ASN Kidney Week 2018.
Prescription opioid use is more common among patients with chronic kidney disease (CKD) compared with members of the general population, according to new findings presente
Although rescheduling a missed hemodialysis appointment can help reduce the risk of subsequent hospitalization, it likely cannot eliminate this risk, according to new research presented at the Am
A new study presented at the American Society of Nephrology’s Kidney Week 2018 suggested that it may be beneficial to consider patients with obesity more favorably for kid
New research presented at the American Society of Nephrology’s Kidney Week 2018 suggests that acute kidney injury is associated with an increased risk of developing dement
